Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma

被引:34
作者
Zhang, Megan Q.
Lin, Fan
Hui, Pei
Chen, Zong-Ming E.
Ritter, Jon H.
Wang, Hanlin L.
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, Lauren V Ackerman Lab Surg Pathol, St Louis, MO USA
[2] Geisinger Med Ctr, Dept Lab Med, Danville, PA 17822 USA
[3] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
关键词
small intestine; colorectal; adenocarcinoma; mucin; small-intestinal mucin antigen; villin; CDX2;
D O I
10.1309/JAF3KVGJHQCJ1QF9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Expression of gastrointestinal biomarkers MUCI, MUC2, MUC5AC, small-intestinal mucin antigen (SIMA), villin, and CDX2 has been studied in colorectal adenocarcinoma (CRC). Little is known, however, about their expression in small-intestinal adenocarcinoma (SIA). We immunohistochemically compared 30 SIAs with 48 CRCs for the expression of these biomarkers. The results showed that all 6 proteins were variably expressed in SIA, but the frequencies of expression were significantly lower than those for CRC with the exception of MUC1 Specifically, positive staining for MUCI, MUC2, MUC5AC, SIMA villin, and CDX2 was observed in 16 (53%), 17 (57%), 12 (40%), 15 (50%), 20 (67%), and 18 (60%) of SlAs and 25 (52%), 43 (90%), 39 (81%), 45 (94%), 47 (98%), and 47 (98%) of CRCs, respectively. In addition, SIAs morefrequently exhibited afocal staining pattern for MUC2, MUC5AC, SIMA, and villin, whereas more diffuse immunoreactivity was evident in CRCs. Focal staining for MUCI and diffuse staining for CDX2 were common for SIAs and CRCs. Furthermore, poorly differentiated SIAs tended to express MUCI more frequently when compared with well- and moderately differentiated SIAs. These observations further support the notion that SIA is immunophenotypically distinct from CRC despite their morphologic similarity.
引用
收藏
页码:808 / 816
页数:9
相关论文
共 35 条
[11]  
Groisman GM, 2005, ARCH PATHOL LAB MED, V129, P920
[12]   Differentiation pathways in duodenal and ampullary carcinomas:: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas [J].
Gürbüz, Y ;
Klöppel, G .
VIRCHOWS ARCHIV, 2004, 444 (06) :536-541
[13]   ABERRANT EXPRESSION OF INTESTINAL MUCIN ANTIGENS ASSOCIATED WITH COLORECTAL-CARCINOMA DEFINED BY A PANEL OF MONOCLONAL-ANTIBODIES [J].
HERTZOG, PJ ;
PILBROW, SJ ;
PEDERSEN, J ;
POLGLASE, AL ;
LAWSON, M ;
LINNANE, AW .
BRITISH JOURNAL OF CANCER, 1991, 64 (05) :799-808
[14]   ONCOFETAL EXPRESSION OF THE HUMAN INTESTINAL MUCIN GLYCOPROTEIN ANTIGENS IN GASTROINTESTINAL EPITHELIUM DEFINED BY MONOCLONAL-ANTIBODIES [J].
HERTZOG, PJ ;
ROBINSON, HC ;
MA, J ;
MACKAY, IR ;
LINNANE, AW .
INTERNATIONAL JOURNAL OF CANCER, 1991, 48 (03) :355-363
[15]   Mucins in cancer: Protection and control of the cell surface [J].
Hollingsworth, MA ;
Swanson, BJ .
NATURE REVIEWS CANCER, 2004, 4 (01) :45-60
[16]  
Howe JR, 1999, CANCER-AM CANCER SOC, V86, P2693, DOI 10.1002/(SICI)1097-0142(19991215)86:12<2693::AID-CNCR14>3.0.CO
[17]  
2-U
[18]   The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas [J].
Kaimaktchiev, V ;
Terracciano, L ;
Tornillo, L ;
Spichtin, H ;
Stoios, D ;
Bundi, M ;
Korcheva, V ;
Mirlacher, M ;
Loda, M ;
Sauter, G ;
Corless, CL .
MODERN PATHOLOGY, 2004, 17 (11) :1392-1399
[19]   Expression of mucins and cytokeratins in primary carcinomas of the digestive system [J].
Lee, MJ ;
Lee, HS ;
Kim, WH ;
Choi, Y ;
Yang, MH .
MODERN PATHOLOGY, 2003, 16 (05) :403-410
[20]   CDX-2, a new marker for adenocarcinoma of gastrointestinal origin [J].
Li, MK ;
Folpe, AL .
ADVANCES IN ANATOMIC PATHOLOGY, 2004, 11 (02) :101-105